EUVIMEDEUVIMED entdecken
Übersichtsarbeit

SOHO State of the Art Updates and Next Questions | Accelerated Phase of MPN: What It Is and What to Do About It

Anand A Patel, Olatoyosi Odenike

Clinical Lymphoma Myeloma and Leukemia · 2023

DOI: 10.1016/j.clml.2023.01.011 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Clinical Lymphoma Myeloma and Leukemia, 2023. Verfasst von Anand A Patel und 1 weiteren Autor:innen. Beteiligte Einrichtung: Section of Hematology/Oncology, Department of Medicine, University of Chicago, Chicago, IL. Hauptthemen laut MEDLINE: Myeloproliferative Disorders, Hematopoietic Stem Cell Transplantation. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 60 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Progression of Philadelphia-chromosome negative myeloproliferative neoplasms (MPNs) to the accelerated phase (AP) or blast phase (BP) is associated with poor outcomes. As our understanding of the molecular drivers of MPN progression has grown, there has been increasing investigation into the use of novel targeted approaches in the treatment of these diseases. In this review we summarize the clinical and molecular risk factors for progression to MPN-AP/BP followed by discussion of treatment approach. We also highlight outcomes using conventional approaches such as intensive chemotherapy and hypomethylating agents along with considerations around allogeneic hematopoietic stem cell transplant. We then focus on novel targeted approaches in MPN-AP/BP including venetoclax-based regimens, IDH inhibition, and ongoing prospective clinical trials.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Myeloproliferative DisordersHematopoietic Stem Cell TransplantationHumansProspective StudiesBlast CrisisRisk Factors

Stichwörter der Autor:innen

BCL2 inhibitionBlast-phaseIDH inhibitionTargeted therapyhypomethylating agents

Autor:innen und Institutionen

  • Section of Hematology/Oncology, Department of Medicine, University of Chicago, Chicago, IL.
  • Section of Hematology/Oncology, Department of Medicine, University of Chicago, Chicago, IL. Electronic address: todenike@medicine.bsd.uchicago.edu.

Zitieren

APA

Patel, A. A., & Odenike, O. (2023). SOHO State of the Art Updates and Next Questions | Accelerated Phase of MPN: What It Is and What to Do About It. Clinical Lymphoma Myeloma and Leukemia. https://doi.org/10.1016/j.clml.2023.01.011

Vancouver

Patel AA, Odenike O. SOHO State of the Art Updates and Next Questions | Accelerated Phase of MPN: What It Is and What to Do About It. Clinical Lymphoma Myeloma and Leukemia. 2023. doi:10.1016/j.clml.2023.01.011

BibTeX
@article{Patel2023,
  author = {Patel, Anand A and Odenike, Olatoyosi},
  title = {SOHO State of the Art Updates and Next Questions | Accelerated Phase of MPN: What It Is and What to Do About It},
  journal = {Clinical Lymphoma Myeloma and Leukemia},
  year = {2023},
  doi = {10.1016/j.clml.2023.01.011}
}
Kostenlos starten →